Showing 2481-2490 of 2735 results for "".
- Business News: Hologic to Offload Cynosure for $205Mhttps://modernaesthetics.com/news/business-news-hologic-to-offload-cynosure-for-205m/2472847/Hologic is selling Cynosure medical aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice for a total purchase price of $205 million in cash, subject to certain closing adjustments. This is a tenth of the $1.6B that Hologic, a women
- Update: Instagram Removes Cosmetic Surgery Filtershttps://modernaesthetics.com/news/update-instagram-removes-cosmetic-surgery-filters/2472841/In a move designed to promote mental well being, Instagram, owned by Facebook, is removing all augmented reality filters that depict cosmetic surgery. In addition, the social media giant is striking all effects from the gallery that are associated with plastic surgery and postponing the
- Cynosure Rolls Out StimSure for Muscle Toning in Europe, Middle Easthttps://modernaesthetics.com/news/cynosure-rolls-out-stimsure-for-muscle-toning-in-europe-middle-east/2472839/Cynosure, a division of Hologic, is launching StimSure, a non-invasive electromagnetic technology to build and tone muscle in the abdomen, buttocks and thighs, in Europe and the Middle East. CE marked for muscular atrophy, StimSure can be used to strengthen and tighten the abdomina
- FDA Proposes Boxed Warning on Breast Implant Riskshttps://modernaesthetics.com/news/fda-proposes-boxed-warning-on-breast-implant-risks/2472837/The FDA released a statement on its continued efforts to protect women’s health and enhance safety information available to patients considering breast implants. In draft guidance issued on Oct. 24, the FDA proposed labeling
- Merz: Cellfina for Cellulite Cleared for 5 Years of Benefithttps://modernaesthetics.com/news/merz-cellfina-for-cellulite-cleared-for-5-years-of-benefit/2472836/The FDA has cleared a new indication statement for Cellfina that shows the benefits of treatment last for five years, an increase from the previous three-year indication. Cellfina from Merz demonstrated five-year improvement in the appearance of cellulite on the buttocks and thighs of adult femal
- Obagi at ASDS: Panel to Focus on Inclusionhttps://modernaesthetics.com/news/obagi-at-asds-panel-to-focus-on-inclusion/2472833/Obagi and actor, producer and activist, Priyanka Chopra Jonas, will lead a panel of top dermatologists in a discussion about the importance of diversity and inclusion in medical aesthetics during the annual meeting of the American Society for Dermatologic Surgery (ASDS) in Chicago next week. 
- Happy 30th, Botox!https://modernaesthetics.com/news/happy-30th-botox/2472832/Botox is turning 30, and Allergan fêted its shining star, Botox Cosmetic, in style at a New York City bash. The event included the debut of Botox Cosmetic’s new packaging and a panel discussion featuring New York City dermatologists Macrene Alexiades-Armenakas, MD, PhD
- British Plastic Surgeons to Vote on Brazilian Butt Lift Banhttps://modernaesthetics.com/news/british-plastic-surgeons-to-vote-on-brazilian-butt-lift-ban/2472830/It’s been called the deadliest cosmetic surgery procedure in the world, and now the British Association of Aesthetic Plastic Surgeons (BAAPS) is launching a formal safety review of Brazilian butt lifts that will culminate with a vote on whether to ban fat grafting buttock augmentation.
- AAFE Launches Medspa Business Academy (MBA)https://modernaesthetics.com/news/aafe-launches-medspa-business-academy-mba/2472828/The American Academy of Facial Esthetics (AAFE) has launched its Medspa Business Academy (MBA) with the goal to assist esthetic medical/dental practices and medical spas across the country in building a successful injectable practice and medical spa business. Early registration discount
- Soliton RAP Update: First Patients Treated in Cellulite Trialhttps://modernaesthetics.com/news/soliton-rap-update-first-patients-treated-in-cellulite-trial/2471872/The first patients in Soliton’s cellulite trial have been treated, the Company reports. "Patient treatments have now begun at the Chicago site,” says Dr. Chris Capelli, President, CEO and co-founder of